Merck News

Company Name Stock Ticker Symbol Market Type
Merck and Co Inc MRK NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
1.95 2.19% 90.88 20:00:00
Open Price Low Price High Price Close Price Prev Close
88.99 88.95 91.03 91.02 88.93
more quote information »

Recent News

Date Time Source Heading
8/12/20228:00IHNWFeaturedInnerScope Hearing Technologies (OTC: INND) Reports Record Revenues for a Profitable Q2 2022
8/08/202208:45IHNWThe Power of Science to Stop a Killer
8/05/202206:01EDGARQuarterly Report (10-q)
8/04/202216:05EDGARStatement of Changes in Beneficial Ownership (4)
8/04/202206:45BWLYNPARZA® (olaparib) Approved in the EU as Adjuvant..
8/03/202221:11TRMNCredit Suisse Sticks to Their Buy Rating for Merck & Company..
8/03/202207:48DJNMerck: Two Phase 3 Keytruda Studies Miss Targets
8/03/202206:45BWMerck and Eisai Provide Update on Phase 3 LEAP-002 Trial..
8/03/202206:40BWMerck Provides Update on Phase 3 KEYNOTE-921 Trial..
7/29/202211:01TRMNMerck Posts Upbeat Q2 Results; Drug Pricing Bill Shakes..
7/29/202208:36TRMNSVB Securities Maintains a Buy Rating on Merck & Company..
7/28/202206:30BWMerck Announces Second-Quarter 2022 Financial Results
7/26/202212:40BWMerck Announces Fourth-Quarter 2022 Dividend
7/20/202207:36DJNMerck Phase 3 Keytruda Study Misses Main Endpoint in HNSCC
7/20/202206:45BWMerck Provides Update on Phase 3 KEYNOTE-412 Trial in..
7/13/202209:35TRMNHere’s Why Merck-Orion Collaboration Is Important
7/13/202206:57DJNMerck, Orion Set Collaboration for ODM-208 Development
7/13/202206:00BWMerck and Orion Announce Global Collaboration for the..
7/07/202206:31DJNSeagen Shares Rise Premarket as Merck Reportedly Moves..
7/05/202214:10EDGARStatement of Changes in Beneficial Ownership (4)
7/05/202214:08EDGARStatement of Changes in Beneficial Ownership (4)
7/05/202214:04EDGARStatement of Changes in Beneficial Ownership (4)
6/29/202207:00BWMerck Announces the Launch of the Merck Digital Sciences..
6/29/202206:45BWMerck to Hold Second-Quarter 2022 Sales and Earnings..
6/27/202208:37TRMNCowen & Co. Keeps Their Hold Rating on Merck & Company (MRK)
6/27/202206:45BWLYNPARZA® (olaparib) Receives Positive Opinion From EU CHMP..
6/24/202207:29DJNMerck Gets EU Approval of Expanded Keytruda Use in Melanoma
6/24/202206:45BWEuropean Commission Approves KEYTRUDA® (pembrolizumab) as..
6/22/202218:28BWCDC’s ACIP Unanimously Votes to Provisionally Recommend Use..
6/22/202207:27DJNMerck: FDA Approves Vaxneuvance Vaccine in Infants, Children
6/22/202206:45BWU.S. FDA Approves Merck’s VAXNEUVANCE™ (Pneumococcal..
6/21/202216:30BWResults From Phase 3 PROpel Trial of LYNPARZA® (olaparib)..
6/21/202216:10BWMerck Announces that Chirfi Guindo will Lead Marketing for..
6/21/202209:45TRMNMizuho Securities Sticks to Their Buy Rating for Merck &..
6/21/202207:56DJNMerck Reports Positive Phase 1/2 Study Results for V116..
6/21/202206:45BWMerck Presents Positive Results from Phase 1/2 Study..
6/20/202203:33TRMNWill Merck acquire Seagen?
6/17/202211:06DJNSeagen Shares Rally After WSJ Reports Merck Mulling a Deal
6/15/202214:22EDGARAnnual Report of Employee Stock Plans (11-k)
6/15/202214:20EDGARAnnual Report of Employee Stock Plans (11-k)
6/15/202214:07EDGARAnnual Report of Employee Stock Plans (11-k)
6/13/202208:08DJNMerck Seeks FDA's OK to Use Keytruda as Adjuvant Lung Cancer..
6/13/202206:45BWFDA Accepts Application for Merck’s KEYTRUDA®..
6/08/202206:51BWMerck to Participate in the 2022 Goldman Sachs 43rd Annual..
6/07/202222:15TRMNMizuho Securities Maintains Their Buy Rating on Merck &..
6/07/202206:45BWMerck and Ridgeback Announce New Data For Investigational..
6/07/202206:30BWMerck to Hold Investor Event to Highlight Oncology Portfolio..
6/06/202203:08DJNNetScientific Says FDA Granted PDS0101 Cancer Treatment Fast..
6/05/202208:00BWAdjuvant Treatment With Merck’s KEYTRUDA® (pembrolizumab)..
6/01/202216:28EDGARStatement of Changes in Beneficial Ownership (4)
6/01/202216:26EDGARStatement of Changes in Beneficial Ownership (4)

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now